JSPR
JSPR
NASDAQ · Biotechnology

Jasper Therapeutics Inc

$13.37
-1.39 (-9.42%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 8 80%
Hold 2 20%
Sell 0 0%
Price Target
Analyst Price Target +203.0% upside
Low Target $28.40
Average Target $40.51
High Target $50.89
Current Price $13.37
Current
$13.37
Target
$40.51
$28.40 $40.51 avg $50.89
Scenario Analysis
Bear Case
$28.40
112.4%
Low target
Base Case
$40.51
+203.0%
Avg target
Bull Case
$50.89
+280.6%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$2.42
452.5% from high
52-Week Low
$0.32
+4,143.1% from low
Target vs 52W High
$40.51
+1,574.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%